Hudson Bay Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
TCM
KCM
Hudson Bay Capital Management's ALT Position: Q1 2023 in Review
Hudson Bay Capital Management sold out of Altimmune (ALT) in Q1 2023, closing a stake of 20,731 shares — an estimated $341K sold.
Hudson Bay Capital Management first reported a position in ALT in Q3 2014 and held it in 16 quarters. The position peaked at $8.35M in Q2 2020. 132 funds tracked by Wall St. Rank hold ALT as of Q1 2023.
- Hudson Bay Capital Management reported no remaining Altimmune position as of Q1 2023 after selling out during the quarter.
- Hudson Bay Capital Management sold 20,731 Altimmune shares in Q1 2023, an estimated $341K.
- Hudson Bay Capital Management first reported a position in Altimmune in Q3 2014 and held it in 16 quarters.
- Hudson Bay Capital Management's Altimmune position peaked at $8.35M in Q2 2020.
- 132 funds tracked by Wall St. Rank held Altimmune as of Q1 2023.
Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.